Picture of Geneuro SA logo

GNRO — Geneuro SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Brief: Geneuro Launches Capital Increase With Indicative Amount Of EUR 5 Million

Feb 1 (Reuters) - Geneuro SA  GNRO.PA :
    * GENEURO LAUNCHES AN OFFERING WITH A COMMITMENT TO
SUBSCRIBE BY
EXISTING SHAREHOLDERS AND ANNOUNCES ITS CASH POSITION AT
DECEMBER 31, 2023
    * CASH POSITION OF EUR 2.8 MILLION, INCLUDING EUR 1 MILLION
OF
RESEARCH TAX CREDIT PRE-FINANCING IMPLEMENTED IN EARLY JANUARY
2024
    * CAPITAL INCREASE DESIGNED TO SECURE FUNDING FOR COMPLETION
OF
POST-COVID PHASE 2 TRIAL, WITH RESULTS EXPECTED IN JUNE 2024,
AND TO EXTEND COMPANY'S FINANCIAL RUNWAY
    * OFFERING OF AN INDICATIVE AMOUNT OF EUR 5 MILLION
    * ISSUE PRICE OF 1.05 EURO PER NEW SHARE, A 17% DISCOUNT
FROM
CLOSING PRICE OF JANUARY 31, 2024
    * SUBSCRIPTION COMMITMENTS OF MINIMUM 60% BY HISTORICAL
SHAREHOLDERS, INSTITUT MÉRIEUX AND SERVIER
    * CLOSING OF OFFERING CONDUCTED THROUGH PRIMARYBID PLATFORM
ON
FEBRUARY 1, 2024 AT 10 P.M. (CET) AND OF RESERVED OFFERING ON
FEBRUARY 2, 2024 BEFORE MARKET OPEN (SUBJECT TO EARLY CLOSING)
    * SETTLEMENT-DELIVERY OF NEW SHARES AND THEIR ADMISSION TO
TRADING
ON REGULATED MARKET OF EURONEXT PARIS ARE SCHEDULED FOR FEBRUARY
7, 2024

Source text for Eikon:  ID:nBw38RMQGa 
Further company coverage:  GNRO.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

Recent news on Geneuro SA

See all news